The University of Alabama at Birmingham (UAB) is at the forefront of medical research, offering numerous clinical trials that aim to improve health outcomes across a variety of conditions. Here's a closer look at some of the studies currently seeking participants:
-
CT-388-104 Study: Focused on individuals aged 18-75 with a BMI of 25 or above and diagnosed with type 2 diabetes, this study tests the safety and effectiveness of a selective GLP-1/GIP investigational drug. Participants may receive the drug or placebo, along with medical care and lifestyle counseling.
-
Nearsightedness in Children Study: Aimed at children aged 8-12 who need glasses or contact lenses, this research explores the potential of a new contact lens to treat nearsightedness. Participants will receive free contact lenses and compensation.
-
Vision Rehabilitation Research: Healthy adults aged 50-59 are needed to help lay the foundation for using a new device, the Bioness Integrated Therapy System (BITS), in treating visual impairments. The study involves short surveys and functional tests, with participants receiving a $25 gift card.
-
DISCOVERY Study: Targeting children aged 9-14 at risk for type 2 diabetes, this study involves in-person and phone visits, lab tests, questionnaires, and physical exams. Families across the US are encouraged to participate to help make a difference for all children.
-
Schizophrenia Study: Adults aged 35-65 with schizophrenia are needed to help researchers understand how the condition affects individuals as they age. The study includes clinical interviews, cognitive tests, MRI scans, and compensation up to $310.
-
Urinary Leakage Study: Individuals aged 65 and older experiencing urine leakage may qualify for this study assessing the effectiveness of hip exercises on pelvic floor muscle strength. Compensation of $100 is provided.
-
HIV Vaccine Study: Adults aged 18-60 living with HIV and with a suppressed viral load are sought for a study testing an experimental HIV vaccine. Compensation and transportation services are available.
-
TRANSCEND-T2D-2 Study: Adults with type 2 diabetes are needed to test the efficacy and safety of an investigational medicine compared to existing treatments. The study involves taking medications and monitoring blood glucose and weight.
-
PRECISION-BP Study: This research investigates the effects of Sacubitril/Valsartan or Valsartan on the body's 24-hour rhythm of natriuretic peptides, related to heart health. Eligible participants must be obese with high blood pressure and no history of heart or kidney problems. Compensation is $575 for completing study visits.
For more information on these studies and how to participate, contact the provided email addresses or phone numbers.
